Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia

Bibliographic Details
Main Authors: Quek, L, David, M, Kennedy, A, Metzner, M, Amatangelo, M, Shih, A, Stoilova, B, Karamitros, D, Quivoron, C, Heiblig, M, Willekens, C, Saada, V, Peniket, A, Bernard, O, Agresta, S, Yen, K, Stein, E, De Botton, S, Thakurta, A, Levine, R, Penard-Lacronique, V, Vyas, P
Format: Conference item
Published: American Society of Hematology 2017
_version_ 1826285398481960960
author Quek, L
David, M
Kennedy, A
Metzner, M
Amatangelo, M
Shih, A
Stoilova, B
Karamitros, D
Quivoron, C
Heiblig, M
Willekens, C
Saada, V
Peniket, A
Bernard, O
Agresta, S
Yen, K
Stein, E
De Botton, S
Thakurta, A
Levine, R
Penard-Lacronique, V
Vyas, P
author_facet Quek, L
David, M
Kennedy, A
Metzner, M
Amatangelo, M
Shih, A
Stoilova, B
Karamitros, D
Quivoron, C
Heiblig, M
Willekens, C
Saada, V
Peniket, A
Bernard, O
Agresta, S
Yen, K
Stein, E
De Botton, S
Thakurta, A
Levine, R
Penard-Lacronique, V
Vyas, P
author_sort Quek, L
collection OXFORD
description
first_indexed 2024-03-07T01:28:14Z
format Conference item
id oxford-uuid:92b2bc3d-af88-4042-89a1-0a3521ed7c9e
institution University of Oxford
last_indexed 2024-03-07T01:28:14Z
publishDate 2017
publisher American Society of Hematology
record_format dspace
spelling oxford-uuid:92b2bc3d-af88-4042-89a1-0a3521ed7c9e2022-03-26T23:27:25ZClonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemiaConference itemhttp://purl.org/coar/resource_type/c_5794uuid:92b2bc3d-af88-4042-89a1-0a3521ed7c9eSymplectic Elements at OxfordAmerican Society of Hematology2017Quek, LDavid, MKennedy, AMetzner, MAmatangelo, MShih, AStoilova, BKaramitros, DQuivoron, CHeiblig, MWillekens, CSaada, VPeniket, ABernard, OAgresta, SYen, KStein, EDe Botton, SThakurta, ALevine, RPenard-Lacronique, VVyas, P
spellingShingle Quek, L
David, M
Kennedy, A
Metzner, M
Amatangelo, M
Shih, A
Stoilova, B
Karamitros, D
Quivoron, C
Heiblig, M
Willekens, C
Saada, V
Peniket, A
Bernard, O
Agresta, S
Yen, K
Stein, E
De Botton, S
Thakurta, A
Levine, R
Penard-Lacronique, V
Vyas, P
Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
title Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
title_full Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
title_fullStr Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
title_full_unstemmed Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
title_short Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
title_sort clonal heterogeneity in differentiation response and resistance to the idh2 inhibitor enasidenib in acute myeloid leukemia
work_keys_str_mv AT quekl clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT davidm clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT kennedya clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT metznerm clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT amatangelom clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT shiha clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT stoilovab clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT karamitrosd clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT quivoronc clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT heibligm clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT willekensc clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT saadav clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT peniketa clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT bernardo clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT agrestas clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT yenk clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT steine clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT debottons clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT thakurtaa clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT leviner clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT penardlacroniquev clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia
AT vyasp clonalheterogeneityindifferentiationresponseandresistancetotheidh2inhibitorenasidenibinacutemyeloidleukemia